- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 237/04 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
Patent holdings for IPC class C07C 237/04
Total number of patents in this class: 217
10-year publication summary
11
|
22
|
24
|
20
|
17
|
15
|
10
|
7
|
11
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Quadriga Biosciences, Inc. | 21 |
9 |
Nocion Therapeutics, Inc. | 46 |
8 |
Alcon, Inc. | 5199 |
7 |
The Regents of the University of California | 19572 |
4 |
BioLegend, Inc. | 47 |
4 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 806 |
4 |
Taisho Pharmaceutical Co., Ltd. | 854 |
4 |
The General Hospital Corporation | 4655 |
3 |
President and Fellows of Harvard College | 5914 |
3 |
BioSphere Medical, Inc. | 35 |
3 |
The Cooper Health System | 32 |
3 |
Daiichi Sankyo Company, Limited | 1873 |
3 |
Hanmi Pharm. Co., Ltd. | 553 |
3 |
Julius-maximilians-universitaet Wuerzburg | 38 |
3 |
Kyowa Hakko Bio Co., Ltd. | 304 |
3 |
SRI International | 1004 |
3 |
The University of Tokyo | 4070 |
3 |
Aardvark Therapeutics Inc. | 46 |
3 |
Novartis AG | 11254 |
2 |
Board of Regents, The University of Texas System | 5641 |
2 |
Other owners | 140 |